Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemoglobin01:24

Hemoglobin

5.9K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
5.9K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

1.5K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.5K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

12.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
12.0K
Multiple Allele Traits01:49

Multiple Allele Traits

36.2K
The Concept of Multiple Allelism
36.2K
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

4.3K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
4.3K
Rh Blood Group01:19

Rh Blood Group

2.2K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of Undiagnosed Depression and Its Sociodemographic and Clinical Correlates Among Adult Patients Attending a Medical Outpatient Department.

Cureus·2025
Same author

Hepatoprotective effects of albiziasaponin-A, ellagitannin and azadirachtin in iron-intoxicated animal model.

Pakistan journal of pharmaceutical sciences·2025
Same author

Comprehensive structural and functional analyses of RAD50 nsSNPs: from prediction to impact assessment.

Frontiers in bioinformatics·2025
Same author

Extraction, GC-MS analysis, cytotoxic, anti-inflammatory and anticancer potential of <i>Cannabis sativa</i> female flower; <i>in vitro</i>, <i>in vivo</i> and <i>in silico</i>.

Frontiers in pharmacology·2025
Same author

Potential of carbon micro/nanofibers derived from lignocellulose biomass valorisation for CO<sub>2</sub> adsorption: A review on decarbonization biotechnology for climate change solutions.

International journal of biological macromolecules·2025
Same author

Impending role of inflammatory markers and their specificity and sensitivity in breast cancer patients.

Scientific reports·2024

Related Experiment Video

Updated: Oct 27, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K

COULD COVID-19 BE A HEMOGLOBINOPATHY?

Tania Ahmed Shakoori1, Muhammad Mansoor Hafeez1, Arif Malik1

  • 1Institute of Molecular Biology and Biotechnology (IMBB), University of Lahore, New Campus, Defense Road 1, KM off Raiwind Road, Lahore, Pakistan.

Acta Clinica Croatica
|July 21, 2021
PubMed
Summary
This summary is machine-generated.

COVID-19 may damage red blood cells via CD147, causing hemoglobinopathy and high-altitude pulmonary edema-like lung injury. This novel mechanism suggests exchange transfusion and anti-CD147 drugs as potential therapies for COVID-19 related acute respiratory distress syndrome.

Keywords:
Acute respiratory distress syndromeCD147COVID-19High altitude pulmonary edema, pathophysiologyHigh altitude pulmonary embolism

More Related Videos

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

10.1K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.8K

Related Experiment Videos

Last Updated: Oct 27, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K
Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

10.1K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.8K

Area of Science:

  • Pathophysiology
  • Hematology
  • Pulmonology

Background:

  • The COVID-19 pandemic highlights the need for understanding disease mechanisms to develop effective therapies.
  • Current understanding of COVID-19 related acute respiratory distress syndrome (ARDS) is incomplete.
  • Radiological findings in COVID-19 ARDS resemble high altitude pulmonary edema (HAPE), prompting investigation into shared pathophysiological pathways.

Purpose of the Study:

  • To propose a novel physiological mechanism for COVID-19 pathogenesis.
  • To explain the development of COVID-19 related ARDS.
  • To identify potential therapeutic targets based on the proposed mechanism.

Main Methods:

  • Review of recent research and clinical observations.
  • Analysis of bioinformatics prediction models.
  • Hypothesizing a novel mechanism involving red blood cell infection and hemoglobinopathy.

Main Results:

  • COVID-19 may infect red blood cells via CD147, leading to hemoglobin damage and hypoxemia.
  • Hypoxemia may induce pulmonary hypoxic vasoconstriction, causing HAPE-like lung lesions.
  • A vicious cycle of alveolar hypoxia and exaggerated hypoxemia is proposed.

Conclusions:

  • The proposed mechanism suggests COVID-19 ARDS may stem from hemoglobinopathy and HAPE-like pathophysiology.
  • Laboratory experiments are recommended to validate these hypotheses.
  • Potential adjunct therapies include exchange transfusion and anti-CD147 drugs.